A race against time: Reduced azithromycin susceptibility in Salmonella enterica serovar Typhi in Pakistan

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)

Abstract

Antimicrobial resistance is an ongoing issue in the treatment of typhoid fever. Resistance to first-line antimicrobials and extensively drug resistant (XDR) Salmonella Typhi isolates in Pakistan have left azithromycin as the only remaining effective oral treatment. Here, we report the emergence of organisms with a single point mutation in acrB gene, implicated in azithromycin resistance, in a S. Typhi isolate from Pakistan. The isolation of this organism is worrisome and highlights the significance of the introduction of typhoid conjugate vaccine in South Asia.

Original languageEnglish (US)
Article numbere00215-20
JournalmSphere
Volume5
Issue number4
DOIs
Publication statusPublished - 1 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antimicrobial resistance
  • Azithromycin higher MIC
  • Pakistan
  • Salmonella typhi
  • Typhoid fever

Fingerprint

Dive into the research topics of 'A race against time: Reduced azithromycin susceptibility in Salmonella enterica serovar Typhi in Pakistan'. Together they form a unique fingerprint.

Cite this